Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IN BRIEF: Genedrive Completes Assay Design For Covid Testing Solution
Genedrive PLC - Manchester-based molecular diagnostics firm - Completes assay design for point-of-care solution for Covid-19 testing and is generating promising analytical data in line with market requirements.
Targeting the end of 2020 for completion of product evaluations, with the full release of the final CE Marked system in the first quarter of the 2021 financial year.
Current stock price: 105.25 pence
Year-to-date change: up sharply from 22.50p
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Genedrive Shares in this article
Latest News
- Oil prices little changed as US-Iran peace efforts hold
10 hours ago - IN BRIEF: Critical Metals agrees GBP2.5 million loan note facility
12 hours ago - IN BRIEF: Phoenix Copper announces over GBP2 million fundraise
12 hours ago - London's FTSE indexes post weekly gain as financials, miners advance
12 hours ago - Two Romanian men jailed for stabbing Iranian journalist in London
13 hours ago - Europe's STOXX 600 clocks best week in over a month as rally broadens
13 hours ago - LONDON MARKET CLOSE: FTSE 100 up as DAX hits record high in Frankfurt
13 hours ago
Related News
EXECUTIVE CHANGES: AB Dynamics appoints CFO; Physiomics names new COO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported...
AB Dynamics
TRADING UPDATES: Secure Trust starts buyback; Smiths News contract win
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Genedrive collects £0.76m R&D tax credit
(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.
Follow the stocks
